New Insights into Heart Failure

Dear Colleagues,

The Special Issue on “New Insights into Heart Failure” seeks to address the advancements in the diagnosis, treatment, and prevention of heart failure (HF).

HF is a clinical syndrome associated with increased morbidity, mortality, and healthcare costs. Heart failure affects about 26 million people worldwide, with more than 960,000 new cases each year. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal fluid accumulation, but the ventricles can be involved together or separately. A wide variety of coexisting pathologies, diseases, or conditions can be found in HF patients, both cardiovascular and non-cardiovascular in nature, exhibiting diverse clinical relevance. The complex inter-relationship of comorbidities and their impact on the cardiovascular system contribute to the features of HF, both with reduced (HFrEF) and preserved ejection fraction (HFpEF). Hence, it can be stated that the coexisting morbidities help us determine the different phenotypes and consequences of HF. Understanding the pathogenesis and its complex associations with comorbidities can play a pivotal role in the prevention and treatment of HF.

This Special Issue invites contributions from researchers, clinicians, and experts in the field to explore the diverse challenges associated with heart failure, encompassing aspects such as etiology, diagnosis, treatment modalities, and patient care.

This Special Issue is now open for submissions (including original research articles, review papers, and case presentations) from clinicians and researchers in cardiovascular medicine and as well as researchers and clinicians specializing in different areas (i.e. metabolic diseases, pneumology, hematology, intensive care medicine, rheumatology, endocrinology, nephrology, internal medicine, family doctors, etc.).

Dr. Nilima Rajpal Kundnani
Prof. Dr. Simona Dragan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• heart failure
• risk factors
• treatment
• device therapy
• biomarkers
• aging
• cardiovascular disease
• coronary artery disease
• valvular heart disease
• arrythmias
• stroke
• COPD
• cancers
• liver cirrhosis